Market Overview

According to The Insight Partners market research study titled ‘Metagenomics Market to 2027 - Global Analysis and Forecasts by Product, Application, and Geography. The global metagenomics market is expected to reach US$ 314.3 Mn in 2027 from US$ 165.8 in 2018. The market is estimated to grow with a CAGR of 7.7% from 2018-2027. The report highlights the trends prevalent in the global metagenomics market and the factors driving the market along with those that act as deterrents to its growth.

The global metagenomics market, based on the product was segmented into instruments and software and consumables. In 2017, the consumables segment held the largest market share of 62.0% of the metagenomics market, by product. This segment is also expected to dominate the market in 2027 owing to extensive research and the availability of consumables by various players. Furthermore, the instruments segment is anticipated to witness the fastest growth rate during the forecast period, 2018 to 2027.

The market is likely to witness rapid growth owing to factors such as increasing venture capital investments, advantages of metagenomics in biotechnology and industrial applications of metagenomics. Additionally, the market is also likely to be accelerated by the potential market in emerging nations is expected to offer significant growth opportunities to the market players to capitalize and expand its customer base in Asian and Latin American regions. However, high capital costs of metagenomics is anticipated to restrain the market growth.

Top Key players - 

• Merck KGaA
• Thermo Fisher Scientific Inc.
• Agilent Technologies
• Qiagen
• Bio-Rad Laboratories, Inc
• Perkinelmer Inc.
• Illumina Inc.
• F.Hoffman-La Roche Ltd.
• Oxford Nanopore Technologies Ltd.
• Pacific Bioscience of California, Inc.